MY122397A - Acyclic antiviral and hydrocortisone combination comprising propylene glycol and alkanoic acid ester - Google Patents
Acyclic antiviral and hydrocortisone combination comprising propylene glycol and alkanoic acid esterInfo
- Publication number
- MY122397A MY122397A MYPI99004979A MYPI9904979A MY122397A MY 122397 A MY122397 A MY 122397A MY PI99004979 A MYPI99004979 A MY PI99004979A MY PI9904979 A MYPI9904979 A MY PI9904979A MY 122397 A MY122397 A MY 122397A
- Authority
- MY
- Malaysia
- Prior art keywords
- propylene glycol
- hydrocortisone
- combination
- acid ester
- alkanoic acid
- Prior art date
Links
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 title abstract 6
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 title 2
- 239000002253 acid Substances 0.000 title 1
- 125000002015 acyclic group Chemical group 0.000 title 1
- 229960000890 hydrocortisone Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 208000029433 Herpesviridae infectious disease Diseases 0.000 abstract 1
- -1 ISOPROPYL Chemical class 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 229940127073 nucleoside analogue Drugs 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803929A SE9803929D0 (sv) | 1998-11-18 | 1998-11-18 | Antiviral formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY122397A true MY122397A (en) | 2006-04-29 |
Family
ID=20413320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI99004979A MY122397A (en) | 1998-11-18 | 1999-11-16 | Acyclic antiviral and hydrocortisone combination comprising propylene glycol and alkanoic acid ester |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1131104B1 (https=) |
| JP (2) | JP2002529520A (https=) |
| KR (1) | KR100608963B1 (https=) |
| CN (1) | CN1160128C (https=) |
| AR (1) | AR023705A1 (https=) |
| AT (1) | ATE288283T1 (https=) |
| AU (1) | AU772435B2 (https=) |
| CA (1) | CA2351463C (https=) |
| DE (1) | DE69923584T2 (https=) |
| DK (1) | DK1131104T3 (https=) |
| EG (1) | EG23853A (https=) |
| ES (1) | ES2233104T3 (https=) |
| HK (1) | HK1042440B (https=) |
| IL (2) | IL142702A0 (https=) |
| MY (1) | MY122397A (https=) |
| NZ (1) | NZ511832A (https=) |
| PT (1) | PT1131104E (https=) |
| SE (1) | SE9803929D0 (https=) |
| TW (1) | TW589191B (https=) |
| WO (1) | WO2000029027A1 (https=) |
| ZA (1) | ZA200103335B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003043628A1 (de) | 2001-11-19 | 2003-05-30 | Medigene Aktiengesellschaft | Arzneimittel zur behandlung von viralen haut- und tumorerkrankungen |
| BRPI0415215B8 (pt) | 2003-10-09 | 2021-05-25 | Medigene Ag | uso de polifenol na preparação de medicamento |
| JP4972062B2 (ja) * | 2008-03-17 | 2012-07-11 | メディヴィル・アクチエボラーグ | 抗ウイルス製剤 |
| EP3836934B1 (en) * | 2018-08-17 | 2023-06-21 | Ilko Ilaç Sanayi Ve Ticaret Anonim Sirketi | Phase stable topical composition comprising acyclovir and hydrocortisone |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW438585B (en) * | 1995-02-06 | 2001-06-07 | Astra Ab | Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections |
| US5760096A (en) * | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
-
1998
- 1998-11-18 SE SE9803929A patent/SE9803929D0/xx unknown
-
1999
- 1999-11-12 NZ NZ511832A patent/NZ511832A/en not_active IP Right Cessation
- 1999-11-12 DK DK99972109T patent/DK1131104T3/da active
- 1999-11-12 KR KR1020017006232A patent/KR100608963B1/ko not_active Expired - Fee Related
- 1999-11-12 WO PCT/SE1999/002043 patent/WO2000029027A1/en not_active Ceased
- 1999-11-12 ES ES99972109T patent/ES2233104T3/es not_active Expired - Lifetime
- 1999-11-12 JP JP2000582073A patent/JP2002529520A/ja active Pending
- 1999-11-12 AT AT99972109T patent/ATE288283T1/de active
- 1999-11-12 PT PT99972109T patent/PT1131104E/pt unknown
- 1999-11-12 CN CNB998133825A patent/CN1160128C/zh not_active Expired - Lifetime
- 1999-11-12 IL IL14270299A patent/IL142702A0/xx active IP Right Grant
- 1999-11-12 CA CA002351463A patent/CA2351463C/en not_active Expired - Lifetime
- 1999-11-12 DE DE69923584T patent/DE69923584T2/de not_active Expired - Lifetime
- 1999-11-12 AU AU14364/00A patent/AU772435B2/en not_active Expired
- 1999-11-12 HK HK02104279.2A patent/HK1042440B/zh not_active IP Right Cessation
- 1999-11-12 EP EP99972109A patent/EP1131104B1/en not_active Expired - Lifetime
- 1999-11-15 TW TW088119865A patent/TW589191B/zh not_active IP Right Cessation
- 1999-11-16 MY MYPI99004979A patent/MY122397A/en unknown
- 1999-11-16 EG EG146899A patent/EG23853A/xx active
- 1999-11-17 AR ARP990105846A patent/AR023705A1/es active IP Right Grant
-
2001
- 2001-04-19 IL IL142702A patent/IL142702A/en not_active IP Right Cessation
- 2001-04-24 ZA ZA200103335A patent/ZA200103335B/en unknown
-
2011
- 2011-04-11 JP JP2011087438A patent/JP5420583B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AR023705A1 (es) | 2002-09-04 |
| SE9803929D0 (sv) | 1998-11-18 |
| EP1131104A1 (en) | 2001-09-12 |
| HK1042440B (zh) | 2005-04-29 |
| CN1326364A (zh) | 2001-12-12 |
| JP5420583B2 (ja) | 2014-02-19 |
| NZ511832A (en) | 2003-09-26 |
| DE69923584T2 (de) | 2006-03-23 |
| HK1042440A1 (en) | 2002-08-16 |
| ATE288283T1 (de) | 2005-02-15 |
| WO2000029027A1 (en) | 2000-05-25 |
| DE69923584D1 (de) | 2005-03-10 |
| IL142702A (en) | 2006-07-05 |
| TW589191B (en) | 2004-06-01 |
| DK1131104T3 (da) | 2005-03-14 |
| JP2002529520A (ja) | 2002-09-10 |
| PT1131104E (pt) | 2005-03-31 |
| EP1131104B1 (en) | 2005-02-02 |
| ZA200103335B (en) | 2002-07-24 |
| CA2351463C (en) | 2009-10-13 |
| JP2011157392A (ja) | 2011-08-18 |
| ES2233104T3 (es) | 2005-06-01 |
| KR100608963B1 (ko) | 2006-08-09 |
| AU1436400A (en) | 2000-06-05 |
| CA2351463A1 (en) | 2000-05-25 |
| EG23853A (en) | 2007-11-06 |
| AU772435B2 (en) | 2004-04-29 |
| CN1160128C (zh) | 2004-08-04 |
| IL142702A0 (en) | 2002-03-10 |
| KR20010075720A (ko) | 2001-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2211389A1 (en) | Novel pharmaceutical combination | |
| TWI265808B (en) | Valdecoxib compositions | |
| PT716600E (pt) | Composicoes para administracao topica contendo derivados do acido 3-benzoilfenilacetico para o tratamento de doencas inflamatorias oftalmicas | |
| MY107341A (en) | Novel hydroxamic acid and n-hydroxyurea derivatives and their use | |
| HUT75089A (en) | Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent | |
| AU2681300A (en) | Solid oral dosage form containing an enhancer | |
| CA2370565A1 (en) | Dermally applicable vitamin d-containing pharmaceutical compositions | |
| BG105379A (en) | Pharmaceutical compositions for the treatment of acute disorders | |
| CA2141953A1 (en) | Pharmaceutical formulations of interleukin-1 inhibitors | |
| AU1937395A (en) | Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic | |
| NZ513096A (en) | Compositions for treating inflammatory response | |
| TR199802060T2 (xx) | Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�. | |
| IT1263013B (it) | Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee. | |
| IL146789A0 (en) | Amorphous nitric esters and their pharmaceutical compositions | |
| EP1310256A3 (en) | Use of prostaglandin A or its derivatives for the treatment of psoriasis | |
| AU1271592A (en) | Malic acid derivatives and compositions for the treatment of psoriasis | |
| PL316656A1 (en) | Free halophantrin base for use in treating marsh-fever and compositions containing same | |
| ES2109131A1 (es) | Composicion farmaceutica que tiene actividad analgesica. | |
| CA2052901A1 (en) | Pharmacologically enhanced formulations | |
| MY122397A (en) | Acyclic antiviral and hydrocortisone combination comprising propylene glycol and alkanoic acid ester | |
| TW349865B (en) | Therapeutic agent for hemorrhoidal diseases | |
| CA2417935A1 (en) | Anti-inflammatory medicament | |
| UA74388C2 (uk) | Фармацевтичні композиції тизоксаніду і нітазоксаніду | |
| HUP0004223A3 (en) | 4-oxo-butynic acids and pharmaceutical composition containing them as active agent | |
| RU95113437A (ru) | (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью |